The effect on the nasopharyngeal flora of 7 days of amoxicillin-clavulanate or 5 days of 800 mg once a day was studied in 50 adults with acute sinusitis. The numbers of potential pathogens and interfering alphahemolytic streptococci were equally reduced after both therapies. However, the number of interfering Prevotella spp. declined more significantly after amoxicillin-clavulanate treatment.
875 mg of AC twice a day for 7 days, and 25 received 800 mg of TE once a day for 5 days. Compliance was assessed by unused-medicine inspection. Patients who failed to take two or more dosages or failed to return their medicine bottles were excluded. The study was granted Institutional Review Board approval. Statistical analysis was done using the t test and the 2 -square test with continuity correction. Nasopharyngeal cultures were obtained with calcium alginate swabs that were immediately plated into media supportive of the growth of aerobic and anaerobic bacteria at the initial outpatient visit prior to therapy and on a follow-up 10 to 12 days later. Culture collectors and the microbiologist were blinded to the therapy. Cultures were processed for the recovery of potential pathogens and two types of organisms known to possess inhibitory activity: AHS and Prevotella spp. Inhibitory activity was tested as previously described (5) against one strain each of recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Processing of specimens, organism identification, and determination of beta-lactamase production were done as previously described (5, 13, 17) .
Intermediate resistance to penicillin was defined as a MIC of 0.1 to 1.0 g/ml, and high resistance was defined as a MIC of Ն2.0 g/ml. MICs were determined using the CLSI (formerly NCCLS) broth microdilution method with Mueller-Hinton broth, supplemented with 5% lysed horse blood (15, 16 
15 (9) 3 (2) a Numbers in parentheses are numbers of isolates with penicillin resistance.
final inoculum of 7 ϫ 10 4 to 1 ϫ 10 5 bacteria was used, and microtiter plates were incubated at 36.5°C in ambient air for 16 to 20 h. MIC end points were read as the lowest concentration of antimicrobial that totally inhibited macroscopically visible growth of the inoculum. Standard quality control strains (ATCC) were included in each run. Isolates were tested against penicillin G, AC, and TE. Susceptibilities were calculated based on CLSI breakpoints.
Before therapy, potential pathogens were isolated from the nasopharynges of 13 (52%) of those treated with AC and 14 (56%) treated with TE. Following therapy, the number of potential pathogens was equally reduced by both therapies. (Table 1) .
A total of 26 interfering AHS were recovered from 22 of the AC-treated patients prior to therapy, and the number declined to 7 recovered from 7 patients after therapy (P Ͻ 0.001). A total of 28 interfering AHS were recovered from 23 of the TE-treated patients prior to therapy, and the number declined to 8 recovered from 7 patients (P Ͻ 0.001) ( Table 2) .
A total of 28 interfering Prevotella isolates were recovered from the 21 of the AC-treated patients prior to therapy, and the number declined to 9 recovered from 8 patients after therapy (P Ͻ 0.001). A total of 27 interfering Prevotella isolates were recovered from the 22 of the TE-treated patients prior to therapy, and the number declined to 21 recovered from 19 patients (P Ͼ 0.05). Twenty-nine of the 55 (53%) interfering Prevotella isolates produced beta-lactamase.
This study compared the effects of two types of antimicrobial therapies, AC and TE, on the nasopharyngeal flora. While both agents are effective against penicillin-susceptible or -resistant potential pathogens, S. pneumoniae, H. influenzae, and M. catarrhalis, they have selective activity against the nasopharyngeal flora. Differences were noted in the recovery of organisms with interfering capability following therapy. While the number of interfering AHS declined after therapy with either AC or TE, the number of interfering Prevotella isolates declined more significantly after AC treatment.
AC is an antimicrobial with broad-spectrum efficacy, active against AHS and penicillin-resistant Prevotella. TE, in contrast, is less effective against Bacteroides fragilis and Fusobacteria in vitro (8) . Although the MICs of TE and AC against Prevotella were similar (11), these organisms seem to survive better in the nasopharyngeal flora following TE therapy compared to AC.
The presence of interfering organisms may play a role in the prevention of respiratory infections. A greater number of interfering organisms and fewer H. influenzae organisms were recovered in the adenoids of non-otitis-prone children compared to otitis-prone children (2) . Interfering organisms inhibit colonization in patients and in vitro growth of pathogens (4) (5) (6) (7) 13) . The production of bacteriocin and other growth-inhibitory substances or utilization of essential nutrients may explain this phenomenon (7) .
This study suggests the potential benefit of an antimicrobial that selectively spares interfering organisms while eliminating potentially pathogens. Further studies are warranted to explore the clinical implications of these findings and how quickly pathogens can recolonize the nasopharynx following therapy with various antimicrobials.
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